The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Dayno Jeffrey M. since 2015.
This trader's CIK number is 1615993.
At the time of last reporting, Dayno Jeffrey M. was the PRESIDENT, CEO of Harmony Biosciences Holdings, Inc.. (stock ticker symbol HRMY).
Also see all insider trading activities at Harmony Biosciences Holdings, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | HRMY | 0 | $0 | 19,293 | $774,247 | 29,793 | $158,588 |
2022 | HRMY | 0 | $0 | 30,000 | $1,726,890 | 30,000 | $246,600 |
2021 | HRMY | 0 | $0 | 50,000 | $1,892,147 | 50,000 | $410,999 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2017 | EGLT | 0 | $0 | 1,072 | $6,919 | 0 | $0 |
2016 | EGLT | 0 | $0 | 2,144 | $15,788 | 0 | $0 |
2015 | EGLT | 0 | $0 | 3,572 | $35,187 | 0 | $0 |
1. Harmony Biosciences Holdings, Inc. (HRMY)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-01-24 | HRMY | Option Ex | 10,500 | .00 | 0 |
2025-01-21 | HRMY | Option Ex | 19,293 | 8.22 | 158,588 |
2025-01-21 | HRMY | Sale | 19,293 | 40.13 | 774,247 |
2022-11-03 | HRMY | Sale | 15,000 | 60.02 | 900,330 |
2022-11-03 | HRMY | Option Ex | 15,000 | 8.22 | 123,300 |
2022-11-01 | HRMY | Option Ex | 15,000 | 8.22 | 123,300 |
2022-11-01 | HRMY | Sale | 15,000 | 55.10 | 826,560 |
2021-10-19 | HRMY | Sale | 18,200 | 43.45 | 790,771 |
2021-10-19 | HRMY | Option Ex | 18,200 | 8.22 | 149,604 |
2021-10-06 | HRMY | Option Ex | 1,800 | 8.22 | 14,796 |
2021-10-06 | HRMY | Sale | 1,800 | 40.10 | 72,178 |
2021-09-07 | HRMY | Option Ex | 10,000 | 8.22 | 82,200 |
2021-09-07 | HRMY | Sale | 10,000 | 37.58 | 375,780 |
2021-08-26 | HRMY | Option Ex | 2,159 | 8.22 | 17,746 |
2021-08-27 | HRMY | Option Ex | 7,841 | 8.22 | 64,453 |
2021-08-26 | HRMY | Sale | 2,159 | 35.01 | 75,582 |
2021-08-27 | HRMY | Sale | 7,841 | 35.16 | 275,697 |
2021-08-10 | HRMY | Option Ex | 9,950 | 8.22 | 81,789 |
2021-08-10 | HRMY | Sale | 9,950 | 30.21 | 300,639 |
2021-07-22 | HRMY | Option Ex | 50 | 8.22 | 411 |
2021-07-22 | HRMY | Sale | 50 | 30.00 | 1,500 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2017-03-31 | EGLT | Sale | 536 | 5.16 | 2,765 |
2017-01-03 | EGLT | Sale | 536 | 7.75 | 4,154 |
2016-09-30 | EGLT | Sale | 536 | 7.69 | 4,121 |
2016-06-30 | EGLT | Sale | 536 | 4.65 | 2,492 |
2016-03-31 | EGLT | Sale | 536 | 6.72 | 3,601 |
2015-12-31 | EGLT | Sale | 536 | 10.40 | 5,574 |
2015-10-26 | EGLT | Sale | 536 | 8.96 | 4,802 |
2015-06-30 | EGLT | Sale | 536 | 15.32 | 8,211 |
2015-02-03 | EGLT | Sale | 2,500 | 8.87 | 22,174 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dayno Jeffrey M. (PRESIDENT, CEO of Harmony Biosciences Holdings, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.